<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03278639</url>
  </required_header>
  <id_info>
    <org_study_id>ERAEP2</org_study_id>
    <nct_id>NCT03278639</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety or Rhythmic Auditory Stimulation (RAS) for Gait and Balance Disorders in Parkinson's Disease</brief_title>
  <acronym>ERA-EP2</acronym>
  <official_title>Randomized, Blind, Controlled Clinical Trial to Assess the Efficacy and Safety or Rhythmic Auditory Stimulation (RAS) for Gait and Balance Disorders in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontifical Catholic University of Argentina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Council of Scientific and Technical Research, Argentina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Nacional Profesor Alejandro Posadas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Buenos Aires</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pontifical Catholic University of Argentina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gait deficits are among the most characteristic and most functionally debilitating signs of
      the motor neuropathology of Parkinson's disease (PD). Rhythmic Auditory Stimulation (RAS) is
      a technique by which a series of auditory stimuli are presented at a fixed rhythm, so that
      patients have to synchronize their movements to the rhythms. In this study, auditory stimuli
      will be constituted by Tango musical pieces, which tempo is modified to adapt to patients'
      walking cadence. Previous results suggested that RAS can increase Tinetti's gait and balance
      and may also improve Health-Related Quality of Life. This will be a randomized, blind,
      controlled clinical trial to further assess RAS efficacy and safety.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized, prospective, blind, controlled clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Both investigators taking care of patients and outcomes assessors will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline in Tinetti scale total score</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change from baseline in Tinetti scale Gait score</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in Tinetti scale Balance score</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in Tinetti scale total score</measure>
    <time_frame>6 months</time_frame>
    <description>training will last for the first 4 weeks. Assessments will be also performed at Month 6 to check lasting effects.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in Timed Up &amp; Go test (TUG)</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in PDQ-39 scores</measure>
    <time_frame>4 weeks</time_frame>
    <description>PDQ-39 is a PD-specific scale for Health-related Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in MDS-UPDRS score</measure>
    <time_frame>4 weeks</time_frame>
    <description>MDS-UPDRS is a measure of disease severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in Beck Depression Index (BDI)</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in MMSE (Mini-Mental State Examination)</measure>
    <time_frame>4 weeks</time_frame>
    <description>MMSE is a measure of cognitive impairment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in Fall diary</measure>
    <time_frame>4 weeks</time_frame>
    <description>patients will have to indicate the number of daily falls over a 15-d period</description>
  </secondary_outcome>
  <other_outcome>
    <measure>change from baseline in PD CRS</measure>
    <time_frame>4 weeks and 6 months</time_frame>
    <description>Parkinson's Disease Cognitive Rating Scale (PD CRS) measures cognitive performance</description>
  </other_outcome>
  <other_outcome>
    <measure>change from baseline in DRS</measure>
    <time_frame>4 weeks and 6 months</time_frame>
    <description>Dementia Rating Scale (DRS) measures cognitive performance</description>
  </other_outcome>
  <other_outcome>
    <measure>change from baseline in TUG</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change from baseline in PDQ-39</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change from baseline in MDS-UPDRS</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change from baseline in BDI</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change from baseline in MMSE</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change from baseline in fall diary</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Rhythmic auditory stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient will receive training for 4 weeks, 3 times per week. Each training session will last 30 minutes. Training will be performed by music therapists board-certified in RAS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Kinesiology</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each patient will receive training for 4 weeks, 3 times per week. Each training session will last 30 minutes. Training will be performed by board-certified kinesio therapists. The objectives of the training sessions will match those of RAS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Rhythmic Auditory Stimulation</intervention_name>
    <description>Training will be directed to ameliorate gait and balance</description>
    <arm_group_label>Rhythmic auditory stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Kinesiology</intervention_name>
    <description>Training will be directed to ameliorate gait and balance</description>
    <arm_group_label>Kinesiology</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically definitive or probable PD diagnosis

          -  Gait disorders (MDS-UPDRS #2.12 =1)

          -  Patients that can be reasonably expected to remain in ON-state during training
             sessions.

        Exclusion Criteria:

          -  Previous use of RAS or kinesiology

          -  MMSE &gt;= 24

          -  BDI &gt;= 17

          -  Patients having undergone PD surgical treatments.

          -  Patients with auditory or visual handicaps
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergio Pampin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Nacional &quot;Prof. Dr. A. Posadas&quot;</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Santiago Perez-Lloret, MD PhD</last_name>
    <phone>005491141834429</phone>
    <email>santiagopl@conicet.gov.ar</email>
  </overall_contact>
  <location>
    <facility>
      <name>Unidad de Neurocirug√≠a Funcional, Hospital Nacional &quot;Profesor Alejandro Posadas&quot;</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fernanda Lopez</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2017</study_first_submitted>
  <study_first_submitted_qc>September 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2017</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pontifical Catholic University of Argentina</investigator_affiliation>
    <investigator_full_name>Santiago Perez Lloret</investigator_full_name>
    <investigator_title>MD PhD CPI</investigator_title>
  </responsible_party>
  <keyword>gait disorders</keyword>
  <keyword>balance disorders</keyword>
  <keyword>music</keyword>
  <keyword>tango</keyword>
  <keyword>rhythmic auditory stimulation</keyword>
  <keyword>health-related quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

